Controlling the structure of cells using light
Optical Control of the Actin Cytoskeleton
This study is exploring how light can be used to control the tiny structures inside cells that help them move and stay strong, with the goal of finding new ways to treat diseases that affect cell movement and structure, and it's being tested on different types of cells, including human ones.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11094410 on NIH RePORTER |
What this research studies
This research focuses on using light to manipulate the actin cytoskeleton, which is crucial for cell movement and structure. By employing photoswitchable molecules that target different forms of actin and associated proteins, the researchers aim to gain precise control over cellular processes. The approach involves testing these compounds in various cell types, including human cells, to understand their effects on cell behavior. This innovative method could lead to advancements in how we treat diseases related to cell movement and structure.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that involve abnormal cell movement or structure, such as cancer or neurodegenerative diseases.
Not a fit: Patients with stable conditions that do not involve cellular movement or structural abnormalities may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that precisely control cell behavior in various medical conditions.
How similar studies have performed: Other research has shown promising results using similar optical control techniques in cellular biology, indicating potential for success in this area.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Trauner, Dirk Hartwig — University of Pennsylvania
- Study coordinator: Trauner, Dirk Hartwig
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.